Hutchmed (China) Limited (HCM) ORD USD0.10
5.50p
(1.83%)
- Add to watchlist
- Create an alert
- This stock can be held in a
5.50p
(1.83%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
5.50p
(1.83%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
292.50p
303.50p
338.00p
£2.57 bn
300.00p
292.30p
173.60p
n/a
15.00p (5.26%) Previous:
15.00p
49,880
n/a
2,000
Performance
| 1 week 1W | 3.44% | 1 year 1Y | 25.05% |
|---|---|---|---|
| 1 month 1M | 7.54% | 2 years 2Y | 42.25% |
| 3 months 3M | 31.62% | 3 years 3Y | 31.91% |
| 6 months 6M | 54.35% | 5 years 5Y | 38.77% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2022 | 31/12/2021 |
|---|---|---|
| Revenue ($m) | 426.41 | 356.13 |
| Profit before tax ($m) | (410.42) | (215.74) |
| Adjusted EPS (¢): | (43.00) | (0.25) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Hutchmed confirms new drug application for fruquintinib in Japan
29 September 2023 10:57
-
Director dealings: IPF non-exec picks up shares, Hutchmed China director linked to sale
14 September 2023 13:09
-
Hutchmed reports progress on two oncology fronts
12 September 2023 11:26
-
Overseas Regulatory Announcement
7 December 2023 10:04
-
Total Voting Rights
30 November 2023 08:30
-
U.S. FDA Approval of FRUZAQLAâ„¢ (fruquintinib)
9 November 2023 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.